1. World Health Organization. Mental Health: New Understanding, New Hope. Geneva, Switzerland: World Health Organization; 2001.
2. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006;367:153–167. PMID:
16413879.
3. Thornton LM, Andersen BL, Schuler TA, Carson WE 3rd. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med 2009;71:715–724. PMID:
19622708.
4. Dekker RL, Moser DK, Tovar EG, Chung ML, Heo S, Wu JR, et al. Depressive symptoms and inflammatory biomarkers in patients with heart failure. Eur J Cardiovasc Nurs 2014;13:444–450. PMID:
24062026.
5. Elovainio M, Aalto AM, Kivimäki M, Pirkola S, Sundvall J, Lönnqvist J, et al. Depression and C-reactive protein: population-based Health 2000 study. Psychosom Med 2009;71:423–430. PMID:
19297307.
6. Wium-Andersen MK, Orsted DD, Nordestgaard BG. Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study. Biol Psychiatry 2014;76:249–257. PMID:
24246360.
7. Lee S, Choe JW, Kim HK, Sung J. High-sensitivity C-reactive protein and cancer. J Epidemiol 2011;21:161–168. PMID:
21368452.
8. Pitsavos C, Tampourlou M, Panagiotakos DB, Skoumas Y, Chrysohoou C, Nomikos T, et al. Association between low-grade systemic inflammation and type 2 diabetes mellitus among men and women from the ATTICA study. Rev Diabet Stud 2007;4:98–104. PMID:
17823694.
9. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 2001;88:3J–6J.
10. Okyay GU, Inal S, Oneç K, Er RE, Paşaoğlu O, Paaolu H, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail 2013;35:29–36. PMID:
23113674.
11. Torun D, Ozelsancak R, Yiğit F, Micozkadıoğlu H. Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients. Clin Exp Hypertens 2012;34:171–175. PMID:
21966945.
12. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044–1053. PMID:
17433516.
13. Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005;88:167–173. PMID:
16126278.
14. Myint AM, Kim YK. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:304–313. PMID:
24184687.
15. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186–191. PMID:
20102916.
16. Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014;36:217–221. PMID:
23786430.
17. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653–657. PMID:
18773982.
18. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55–60. PMID:
17448623.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62. PMID:
14399272.
20. Akdemir A, Türkçapar MH, Orsel SD, Demirergi N, Dag I, Ozbay MH. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 2001;42:161–165. PMID:
11244153.
21. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–3105. PMID:
12813115.
22. Sunbul M, Zincir SB, Durmus E, Sunbul EA, Cengiz FF, Kivrak T, et al. Anxiety and depression in patients with coronary artery disease. Bull Clin Psychopharmacol 2013;23:345–352.
23. Dinan TG. Inflammatory markers in depression. Curr Opin Psychiatry 2009;22:32–36. PMID:
19122532.
24. Hashmi AM, Butt Z, Umair M. Is depression an inflammatory condition? A review of available evidence. J Pak Med Assoc 2013;63:899–906. PMID:
23901717.
25. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:273–279. PMID:
16101533.
26. Kruk M, Przyłuski J, Kalińczuk Ł, Pregowski J, Deptuch T, Kadziela J, et al. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 2008;72:205–211. PMID:
18219155.
27. Andreoli C, Bassi A, Gregg EO, Nunziata A, Puntoni R, Corsini E. Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins. Clin Chem Lab Med 2015;53:57–64. PMID:
25029083.
28. Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 2006;18:667–677. PMID:
16864557.
29. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–1695. PMID:
15843671.